Cellectis Change in Payables and Accrued Expense (Quarterly) Analysis

Cellectis SA (CLLS)

3.90 -0.09 (-2.26%) USD | NASDAQ | Feb 20, 16:00

3.97 +0.07 (+1.79%) After-Hours: 20:00

View Change in Payables and Accrued Expense (Quarterly) for CLLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Change in Payables and Accrued Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Change in Payables and Accrued Expense (Quarterly) Benchmarks

Start Trial

EDAP TMS SA	--
DBV Technologies SA	Upgrade
Ascendis Pharma A/S	Upgrade
Akari Therapeutics Plc	Upgrade
Biodexa Pharmaceuticals Plc	--